Menu Search
Equities

Akeso Inc

4RY:MUN

Akeso Inc

Actions
  • Price (EUR)9.35
  • Today's Change0.45 / 5.06%
  • Shares traded265.00
  • 1 Year change+68.47%
  • Beta--
Data delayed at least 15 minutes, as of Nov 25 2024 07:14 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Akeso Inc is an investment holding company mainly engaged in the research and development of biological products. The Company is dedicated to addressing global unmet medical needs in oncology, immunology and other therapeutic areas. The Company's main products include AK104, AK105, AK112 and AK109. The Company conducts its businesses within the China market and to overseas markets.

  • Revenue in HKD (TTM)2.02bn
  • Net income in HKD-790.79m
  • Incorporated2019
  • Employees2.82k
  • Location
    Akeso IncNo.6 Shennong RoadHuoju Development ZoneZhongshan 528437ChinaCHN
  • Phone+86 76 089873998
  • Fax+86 76 089873900
  • Websitehttps://www.akesobio.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.